Tele-ophthalmology for diabetic retinopathy screening: 8 years of experience;Teleoftalmología para el cribado de la retinopatía diabética: experiencia de 8 años

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 92, Issue 2, 2017, Pages 63-70

  Pareja Rios A ^a   Bonaque Gonzalez S ^b,c   Serrano Garcia M ^a   Cabrera Lopez F ^d   Abreu Reyes, P ^e   Marrero Saavedra, M D ^f  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^e HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Optical coherence tomography; Primary health care; Telemedicine

Indexed keywords

MYDRIATIC AGENT; TROPICAMIDE;

DIABETIC RETINOPATHY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MASS SCREENING; OPHTHALMOLOGY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PHOTOGRAPHY; PROCEDURES; RETROSPECTIVE STUDY; SPAIN; TELEMEDICINE; VISUAL SYSTEM EXAMINATION;

DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MYDRIATICS; OPHTHALMOLOGY; PHOTOGRAPHY; RETROSPECTIVE STUDIES; SPAIN; TELEMEDICINE; TROPICAMIDE;

EID: 85002262372     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oftal.2016.08.006     Document Type: Article

References (31)

1. 1 Harjutsalo, V., Sjoberg, L., Tuomilehto, J., Time trends in the incidence of type 1 diabetes in Finnish children: A cohort study. Lancet. 371 (2008), 1777–1782.
2. 2 Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 87 (2010), 4–14.
3. 3 The International Diabetes Federation. Diabetes Atlas. 6th ed. IDF; 2013.
4. 4 Soriguer, F., Goday, A., Bosch-Comas, A., Bordiú, E., Calle-Pascual, A., Carmena, R., et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia. 55 (2012), 88–93.
5. 5 Congdon, N., O'Colmain, B., Klaver, C.C., Klein, R., Muñoz, B., Friedman, D.S., et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122 (2004), 477–485.
6. 6 Friedman, D.S., Congdon, N.G., Kempen, J., Tielsch, J.M., Vision problems in the U. S.: Prevalence of adult vision impairment and age-related eye disease in America. 2002, The Silver Book, Schaumburg, IL.
7. 7 Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes and prediabetes in the United States. 2011, U. S. Department of Health and Human Services, Atlanta.
8. 8 American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 33:Suppl 1 (2010), S11–S61.
9. 9 American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines: diabetic retinopathy. 2008, American Academy of Ophthalmology, San Francisco, CA.
10. 10 Cheung, N., Mitchell, P., Wong, T.Y., Diabetic retinopathy. Lancet. 376 (2010), 124–136.
11. 11 Sprafka, J.M., Fritsche, T.L., Baker, R., Kurth, D., Whipple, D., Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med. 150 (1990), 857–861.
12. 12 González-Clemente, J.M., Diabetes mellitus no dependiente de insulina: asistencia en un área de Barcelona. Med Clin (Barc). 108 (1997), 91–97.
13. 13 Espinás, J., Salla, R.M., Bellvehí, M., Reig, E., Iruela, T., Muñoz, E., et al. Reevaluación del programa de diabetes mellitus tipo II. Propuesta de indicadores de calidad. Aten Primaria. 11 (1993), 123–126.
14. 14 Palacios, M.S., Vernet, M.V., Sáez, P.L., Figueras, E.T., Sala, M.F., Características sociodemográficas y clínicas de una población de pacientes con diabetes mellitus. Aten Primaria. 29 (2002), 474–480.
15. 15 Hautala, N., Aikkila, R., Korpelainen, J., Keskitalo, A., Kurikka, A., Falck, A., et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol. 92 (2014), 582–587.
16. 16 Hautala, N., Hyytinen, P., Saarela, V., Hägg, P., Kurikka, A., Runtti, M., et al. A mobile eye unit for screening of diabetic retinopathy and follow-up of glaucoma in remote locations in northern Finland. Acta Ophthalmol. 87 (2009), 912–913.
17. 17 Jivraj, I., Ng, M., Rudnisky, C.J., Dimla, B., Tambe, E., Nathoo, N., et al. Prevalence and severity of diabetic retinopathy in Northwest Cameroon as identified by teleophthalmology. Telemed J E Health. 17 (2011), 294–298.
18. 18 Peng, J., Zou, H., Wang, W., Fu, J., Shen, B., Bai, X., et al. Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Serv Res., 11, 2011, 250.
19. 19 Sender Palacios, M.J., Vernet Vernet, M., Maseras Bové, M., Salvador Playà, A., Pascual Batlle, L., Ondategui Parra, J.C., et al. Oftalmopatía en la diabetes mellitus: detección desde la Atención Primaria de salud. Aten Primaria. 43 (2011), 41–48.
20. 20 Deb-Joardar, N., Germain, N., Thuret, G., Manoli, P., Garcin, A.F., Millot, L., et al. Screening for diabetic retinopathy by ophthalmologists and endocrinologists with pupillary dilation and a nonmydriatic digital camera. Am J Ophthalmol. 140 (2005), 814–821.
21. 21 Beynat, J., Charles, A., Astruc, K., Metral, P., Chirpaz, L., Bron, A.M., et al. Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab. 35 (2009), 49–56.
22. 22 Surendran, T.S., Raman, R., Teleophthalmology in diabetic retinopathy. J Diabetes Sci Technol. 8 (2014), 262–266.
23. 23 Lopez-Bastida, J., Cabrera-Lopez, F., Serrano-Aguilar, P., Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med. 24 (2007), 403–407.
24. 24 Cabrera-López, F., Cardona-Guerra, P., López-Bastida, J., Díaz-Arriaga, J., Evaluación de la efectividad y coste-efectividad de la imagen digital en el diagnóstico de la retinopatía diabética. Arch Soc Canar Oftal. 15 (2004), 21–31.
25. 25 Chasan, J.E., Delaune, B., Maa, A.Y., Lynch, M.G., Effect of a teleretinal screening program on eye care use and resources. JAMA Ophthalmol. 132 (2014), 1045–1051.
26. 26 Jones, S., Edwards, R.T., Diabetic retinopathy screening: A systematic review of the economic evidence. Diabet Med. 27 (2010), 249–256.
27. 27 Whited, J.D., Datta, S.K., Aiello, L.M., Aiello, L.P., Cavallerano, J.D., Conlin, P.R., et al. A modelled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 11 (2005), 641–651.
28. 28 Javitt, J.C., Aiello, L.P., Chiang, Y., Ferris, F.L. III, Canner, J.K., Greenfield, S., Preventive eye care in people with diabetes is cost-saving to the federal government: Implications for health-care reform. Diabetes Care. 17 (1994), 909–917.
29. 29 Abreu Reyes, P., Gil Hernández, M.A., Abreu González, R., Telemedicina en el screening de la retinopatía diabética: nuestra experiencia. Arch Soc Canar Oftal. 14 (2003), 21–24.
30. 30 López Bastida, J., Soto Pedre, E., Cabrera López, F.A., Revisión sistemática y análisis coste-efectividad del cribado de retinopatía diabética con retinógrafo no midriático de 45° mediante imágenes interpretadas por oftalmólogos frente a médicos de familia. 2008, Servicio Canario de Salud, Santa Cruz de Tenerife.
31. 31 Murgatroyd, H., Ellingford, A., Cox, A., Binnie, M., Ellis, J.D., MacEwen, C.J., Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 88 (2004), 920–924.